The FDA approved Amgen and Wyeth Pharmaceuticals drug, Enbrel (etanercept), to inhibit the progression of structural damage in patients with active psoriatic arthritis and reduce its signs and symptoms.
Indoor Tanning and Melanoma
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Tips to Organize the Digital Chaos with Alina Bridges, DO
Berdamizer Gel Safe, Well-Tolerated in Patients With Molluscum Contagiosum